NANP antibody
Ref. 3D-10R-7045
| 100µl | 1,084.00 € |
Product Information
The NANP antibody is a monoclonal antibody that specifically targets the catechol-o-methyltransferase (COMT) enzyme. This antibody has been extensively studied in the field of Life Sciences and has shown promising results as a potential therapeutic agent. The NANP antibody binds to COMT and inhibits its activity, leading to increased levels of vasoactive intestinal peptide (VIP). VIP is an important regulatory peptide involved in various physiological processes, including immune response modulation and cell survival.
In addition to its role in regulating VIP levels, the NANP antibody has also been shown to have cytotoxic effects on certain cell types. It can induce apoptosis, or programmed cell death, in cells expressing high levels of necrosis factor-related apoptosis-inducing ligand (TRAIL) receptors. This makes it a potential candidate for targeted cancer therapy.
Furthermore, the NANP antibody has been found to inhibit the activity of protein kinases, which are enzymes involved in cell signaling pathways. By blocking these kinases
Chemical properties
Technical inquiry about: 3D-10R-7045 NANP antibody
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
